Tryg A/S
11.3.2021 18:55:23 CET | Globenewswire | Press release
Statement of transactions by members of senior management and their related parties in shares, issued by Tryg and related securities, cf. article 19 of the EU Regulation 596/2014.
Members of the Supervisory Board and a related party have carried out transactions in connection with Tryg's rights issue, see https://tryg.com/en/emission
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Jukka Pertola |
| 2. | Reason for notification | |
| a) | Position/status | Chairman |
| b) | Initial notification/ amendment | Initial notification |
| 3. | Details of the issuer | |
| a) | Name | Tryg A/S |
| b) | LEI | 213800ZRS8AC4LSTCE39 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Shares (exercise of subscription rights) DK0061534534 |
| b) | Name of transaction | Exercise of subscription rights in connection with rights issue |
| c) | Price(s) and volume(s) | Price(s): DKK 105 per interim share Volume(s): 7,000 interim shares through exercise of 42,000 subscription rights |
| d) | Aggregated information
| 7,000 interim shares through exercise of 42,000 subscription rights DKK 735,000 |
| e) | Date of transaction | 2021-03-11 |
| f) | Place of transaction | Outside a trading venue (XOFF) |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | ThjømøeKranen AS |
| 2. | Reason for notification | |
| a) | Position/status | Closely associated person to Mari Thjømøe, Board member of Tryg A/S |
| b) | Initial notification/ amendment | Initial notification |
| 3. | Details of the issuer | |
| a) | Name | Tryg A/S |
| b) | LEI | 213800ZRS8AC4LSTCE39 |
| 4.A | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Shares (exercise of subscription rights) DK0061534534 |
| b) | Name of transaction | Exercise of subscription rights in connection with rights issue |
| c) | Price(s) and volume(s) | Price(s): DKK 105 per interim share Volume(s): 10,017 interim shares through exercise of 60,102 subscription rights |
| d) | Aggregated information
| 10,017 interim shares through exercise of 60,102 subscription rights DKK 1,051,785 |
| e) | Date of transaction | 2021-03-10 |
| f) | Place of transaction | Outside a trading venue (XOFF) |
| 4.B | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Subscription rights DKK0061534450 |
| b) | Name of transaction | Purchase of subscription rights in connection with rights issue |
| c) | Price(s) and volume(s) | Price(s): DKK 4.966 Volume(s): 15,000 subscription rights |
| d) | Aggregated information
| 15,000 subscription rights DKK 74,490 |
| e) | Date of transaction | 2021-03-10 |
| f) | Place of transaction | NASDAQ Copenhagen A/S (XCSE) |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Elias Bakk |
| 2. | Reason for notification | |
| a) | Position/status | Board Member |
| b) | Initial notification/ amendment | Initial notification |
| 3. | Details of the issuer | |
| a) | Name | Tryg A/S |
| b) | LEI | 213800ZRS8AC4LSTCE39 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Shares (exercise of subscription rights) DK0061534534 |
| b) | Name of transaction | Exercise of subscription rights in connection with rights issue |
| c) | Price(s) and volume(s) | Price(s): DKK 105 per interim share Volume(s): 1,412 interim shares through exercise of 8,472 subscription rights |
| d) | Aggregated information
| 1,412 interim shares through exercise of 8,472 subscription rights DKK 148,260 |
| e) | Date of transaction | 2021-03-10 |
| f) | Place of transaction | Outside a trading venue (XOFF) |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Tina Snejbjerg |
| 2. | Reason for notification | |
| a) | Position/status | Board Member |
| b) | Initial notification/ amendment | Initial notification |
| 3. | Details of the issuer | |
| a) | Name | Tryg A/S |
| b) | LEI | 213800ZRS8AC4LSTCE39 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Shares (subscription rights) DK0061534534 |
| b) | Name of transaction | Sale of subscription rights in connection with rights issue |
| c) | Price(s) and volume(s) | Price(s): DKK 6.29 Volume(s): 1,778 subscription rights |
| d) | Aggregated information
| 1,778 subscription rights DKK 11,184 |
| e) | Date of transaction | 2021-03-11 |
| f) | Place of transaction | NASDAQ Copenhagen A/S (XCSE) |
Further information
Visit tryg.com or contact Investor Relations:
Investor Relations Officer, Gianandrea Roberti. Telephone +45 20 18 82 67 or
e-mail gianandrea.roberti@tryg.dk
Investor Relations Manager, Peter Brondt. Telephone +45 22 75 89 04 or
e-mail peter.brondt@tryg.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Rocket Lab Corporation28.3.2026 11:39:53 CET | Press release
Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency
Vivoryon Therapeutics N.V.28.3.2026 07:00:00 CET | Press release
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
